Co-Authors
This is a "connection" page, showing publications co-authored by Gabriella Fabbrocini and Steven Nisticò.
Connection Strength
0.285
-
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19. Dermatol Ther. 2021 11; 34(6):e15111.
Score: 0.060
-
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. Expert Opin Biol Ther. 2021 02; 21(2):271-277.
Score: 0.058
-
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy. J Eur Acad Dermatol Venereol. 2020 Dec; 34(12):e770-e772.
Score: 0.056
-
Is climate change the next pandemic for dermatology? Lessons from COVID-19. Dermatol Ther. 2020 Jul; 33(4):e13682.
Score: 0.055
-
COVID-19, quarantine, and atopic dermatitis. Med Hypotheses. 2020 10; 143:109852.
Score: 0.055